未登录

B

Bart Keymeulen

Vrije Universiteit Brussel

H指数:41

被引数:7,795

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Markers of beta cell and alpha cell mass in human stem cell-generated implants with glycemic control at human setpoint

β细胞和α细胞质量标志物：在具有血糖控制功能的人类干细胞衍生植入物中，血糖维持在人体设定点水平

Stem Cells Translational Medicine

IF4.9

2026-08-140

OAAI

Psychosocial aspects in diabetes care: An observational study at an outpatient academic diabetes specialist centre in a metropolitan capital

糖尿病护理中的心理社会方面：在首都一家门诊学术糖尿病专科中心进行的观察性研究

Patient Education and Counseling

IF3.1

2026-04-150

PRE

Cost-utility analysis of Dexcom G6 real-time continuous glucose monitoring versus FreeStyle Libre 1 intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in Belgium

IF10.2

2024-01-181

PRE

Encapsulated stem cell-derived β cells exert glucose control in patients with type 1 diabetes

NATURE BIOTECHNOLOGY

IF41.7

2023-11-2722

OAAI

Baseline plasma proinsulin response to glucose for predicting therapeutic response to otelixizumab in recent-onset type 1 diabetes

基线血浆胰岛素原对葡萄糖的反应可预测近期发作的1型糖尿病对otelixizumab的治疗反应

DIABETES RESEARCH AND CLINICAL PRACTICE

IF7.4

2023-11-011

OAAI

Post hoc analysis of a randomized, double-blind, prospective trial evaluating a CXCR1/2 inhibitor in new-onset type 1 diabetes: endo-metabolic features at baseline identify a subgroup of responders

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2023-06-202

OAAI

First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes

IF8.3

2023-05-248

OAAI

Comparison of Omentum and Subcutis as Implant Sites for Device-Encapsulated Human iPSC-Derived Pancreatic Endoderm in Nude Rats

CELL TRANSPLANTATION

IF3.2

2023-04-272

OAAI

Non-HLA polymorphisms diversely impact progression of preclinical islet autoimmunity in distinct subgroups and stages

DIABETES RESEARCH AND CLINICAL PRACTICE

IF7.4

2023-03-010

PRE

CTLA4, SH2B3, and CLEC16A diversely affect the progression of early islet autoimmunity in relatives of Type 1 diabetes patients

CLINICAL AND EXPERIMENTAL IMMUNOLOGY

IF3.8

2023-01-093

OAAI

The Impact of Baseline User Characteristics on the Benefits of Real-Time Versus Intermittently Scanned Continuous Glucose Monitoring in Adults With Type 1 Diabetes: Moderator Analyses of the ALERTT1 Trial

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY

IF3.7

2022-09-293

OA

Ladarixin, an inhibitor of the interleukin-8 receptors CXCR1 and CXCR2, in new-onset type 1 diabetes: A multicentre, randomized, double-blind, placebo-controlled trial

DIABETES OBESITY & METABOLISM

IF5.7

2022-07-0426

OAAI

Utility of Islet Cell Preparations From Donor Pancreases After Euthanasia

CELL TRANSPLANTATION

IF3.2

2022-05-184

OAAI

Function and composition of pancreatic islet cell implants in omentum of type 1 diabetes patients

AMERICAN JOURNAL OF TRANSPLANTATION

IF8.2

2022-03-0110

PRE

Lipohypertrophy Monitoring Study (LIMO): Effect of single use of 4 mm pen needles combined with education on injection site rotation on glycaemic control: Confirmation of an unpleasant truth

DIABETIC MEDICINE

IF3.4

2021-09-2914

PREAI

Relationship Between Time in Range, Glycemic Variability, HbA1c, and Complications in Adults With Type 1 Diabetes Mellitus

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2021-09-1768

OA

Genetic variation at ERBB3/IKZF4 and sexual dimorphism in epitope spreading in single autoantibody-positive relatives

IF10.2

2021-08-264

OAAI

The MicroRNA Landscape of Acute Beta Cell Destruction in Type 1 Diabetic Recipients of Intraportal Islet Grafts

IF5.2

2021-07-045

OAAI

Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial

IF88.5

2021-06-01115

OAAI

Formation of amyloid in encapsulated human pancreatic and human stem cell-generated beta cell implants

AMERICAN JOURNAL OF TRANSPLANTATION

IF8.2

2021-06-013

OAAI